Home / Going-concern warnings / Edesa Biotech, Inc.
Filed 2025-12-12 路 Form 10-K 路 Accession 0001171843-25-007914 nano
Price before filing: $1.77 (2025-12-11 close, split/dividend-adjusted)
Market cap at flag: $13.9M (2025-12-12) 路 Latest: $23.1M (2026-10-16)
| Window | EDSA | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -16.4% | +1.2% | -17.6% | 2026-01-12 |
| 90 days | +260.5% | -3.1% | +263.5% | 2026-03-12 |
| 180 days | +194.4% | +5.9% | +188.5% | 2026-06-10 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"As discussed in Note 1 of the consolidated financial statements, the Company has incurred a net comprehensive loss and negative cash flows from operations and has accumulated deficit, which raises substantial doubt about its ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Going-concern opinion issued by: MNP LLP
Source: independent auditor report in Form 10-K (period 2025-09-30)
Why this score: in auditor's report
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.